drugset
Drugs / 2'-Fucosyllactose
last change May 2025 re-read 3 minutes ago

2'-Fucosyllactose

also known as 2'-o-fucosyllactose · 2'-o-l-fucosyl-d-lactose · Lactose, 2'-o-fucosyl-

Other / unclassified

Developed for
Crohn disease · disease related to hematopoietic stem cell transplant · ulcerative colitis
Investigated by
Children's Hospital Medical Center, Cincinnati · Broad Institute of MIT and Harvard · Connecticut Children's Medical Center · Nationwide Children's Hospital · University of Cincinnati

Trials 2

today NCT04263597 · Ph 1/2 NCT03847467 · Ph 1/2
20202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT04263597 Aug 2020 → May 2025 disease related to hematopoietic stem cell transplant Children's Hospital Medical Center, Cincinnati Completed No outcome recorded
Phase 1/2 NCT03847467 Sep 2019 → Jun 2027 expected Crohn disease, ulcerative colitis Children's Hospital Medical Center, Cincinnati Recruiting No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as 2'-fucosyllactose ClinicalTrials.gov intervention name — accepted as the source's own label NCT04263597 ↗
1

NCT03847467 ↗
Known as 2'-o-fucosyllactose ChEMBL registry synonym — accepted as the source's own label CHEMBL4297252 ↗
Known as 2'-o-l-fucosyl-d-lactose ChEMBL registry synonym — accepted as the source's own label CHEMBL4297252 ↗
Known as Lactose, 2'-o-fucosyl- ChEMBL registry synonym — accepted as the source's own label CHEMBL4297252 ↗
Modality Other / unclassified “Human milk oligosaccharide prebiotic dietary supplement” NCT03847467 ↗
Route Oral “They will be instructed to drink this daily by adding the required amount to food or drink.” NCT04263597 ↗